<PAGE>
                                
         UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                                
                      WASHINGTON, DC  20549
                                
                                
                            FORM 10-Q
                                
   (MARK ONE) QUARTERLY REPORT / X / OR TRANSITION REPORT /  /
               PURSUANT TO SECTION 13 OR 15(d) OF
               THE SECURITIES EXCHANGE ACT OF 1934



For the quarter ended
October 31, 1998                       Commission File No. 1-5865



                     GERBER SCIENTIFIC, INC.
                ---------------------------------
                   (Exact name of Registrant as
                    specified in its charter)



           CONNECTICUT                             06-0640743
 -------------------------------              ---------------------
 (State or other jurisdiction of                  (IRS Employer
  incorporation or organization)               Identification No.)


 83 Gerber Road West, South Windsor, Connecticut       06074
------------------------------------------------- ---------------
    (Address of principal executive offices)         (Zip Code)
                                                          
                                                          
                                                          
Registrant's Telephone Number, including area      (860) 644-1551
code                                              ---------------


Indicate  by check mark whether the registrant (1) has filed  all
reports  required  to be filed by Section  13  or  15(d)  of  the
Securities  Exchange Act of 1934 during the preceding  12  months
(or  for such shorter period that the registrant was required  to
file  such  reports)  and  (2) has been subject  to  such  filing
requirements for the past 90 days.


                     Yes  / X / .   No /    /.

At  October  31, 1998, 22,828,723 shares of common stock  of  the
Registrant were outstanding.

<PAGE 1>

                     GERBER SCIENTIFIC, INC.
                        AND SUBSIDIARIES
            CONTENTS OF QUARTERLY REPORT ON FORM 10-Q
                                
                 Quarter Ended October 31, 1998


                                                             PAGE



Part I - Financial Information

  Item 1. Consolidated Financial Statements:

           Statement of Earnings for the three months
           ended October 31, 1998 and 1997                   2
           
           Statement of Earnings for the six months
           ended October 31, 1998 and 1997                   3
           
           Balance Sheet at October 31, 1998 and
           April 30, 1998                                  4-5
           
           Statement of Cash Flows for the six months
           ended October 31, 1998 and 1997                   6
           
           Notes to Financial Statements                     7
           
           Independent Accountants' Report                  13

  Item 2. Management's Discussion and Analysis of
           Financial Condition and Results of Operations     14


Part II - Other Information

  Item 4.  Submission of Matters to a Vote of Security
          Holders                                           20
  
  Item 5. Other Information                                 20

  Item 6.  Exhibits and Reports on Form 8-K                 21


Signature                                                    22

Exhibit Index                                                23


<PAGE 2>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENT OF EARNINGS

------------------------------------------------------------
                                         In thousands
                                  (except per share amounts)
------------------------------------------------------------
Three Months Ended October 31,             1998       1997
------------------------------------------------------------
                                                    
Revenue:                                            
                                                    
  Product sales                         $137,992     $94,734
  Service                                 12,598      11,658
                                         -------     -------
                                         150,590     106,392
                                         -------     -------
                                                            
Costs and Expenses:                                         
                                                            
  Cost of product sales                   81,269      51,792
  Cost of service                          7,333       7,563
  Selling, general and administrative     39,593      31,764
  Research and development expenses        7,645       7,765
                                         -------     -------
                                         135,840      98,884
                                         -------     -------
                                                            
Operating income                          14,750       7,508
                                                            
Other income                                 937         670
Interest expense                         (3,352)         (82)
                                         -------     -------
                                                            
Earnings before income taxes              12,335       8,096
                                                            
Provision for income taxes                 4,600       2,600
                                         -------     -------
                                                
Net earnings                            $  7,735     $ 5,496
                                         =======     =======
                                                            
Per share of common stock:                                  
  Basic                                 $    .34     $   .24
  Diluted                               $    .33     $   .24
                                                            
  Dividends                             $    .08     $   .08
                                                            
Average shares outstanding:                                 
  Basic                                   22,789      22,679
  Diluted                                 23,487      23,325
                                                            
                     See Accompanying Notes

<PAGE 3>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENT OF EARNINGS

------------------------------------------------------------
                                         In thousands
                                  (except per share amounts)
------------------------------------------------------------
Six Months Ended October 31,               1998       1997
------------------------------------------------------------
                                                    
Revenue:                                            
                                                    
  Product sales                         $280,158    $182,144
  Service                                 24,091      23,209
                                         -------     -------
                                         304,249     205,353
                                         -------     -------
                                                            
Costs and Expenses:                                         
                                                            
  Cost of product sales                  165,137      99,880
  Cost of service                         14,020      15,380
  Selling, general and administrative     81,349      62,707
  Research and development expenses       15,273      15,353
                                         -------     -------
                                         275,779     193,320
                                         -------     -------
                                                            
Operating income                          28,470      12,033
                                                            
Other income                               1,197       3,010
Interest expense                          (6,510)      (176)
                                         -------     -------
                                                            
Earnings before income taxes              23,157      14,867
                                                            
Provision for income taxes                 8,700       4,800
                                         -------     -------
                                                
Net earnings                            $ 14,457    $ 10,067
                                         =======     =======
                                                            
Per share of common stock:                                  
  Basic                                 $    .64    $    .44
  Diluted                               $    .62    $    .43
                                                            
  Dividends                             $    .16    $    .16
                                                            
Average shares outstanding:                                 
  Basic                                   22,731      23,001
  Diluted                                 23,500      23,518
                                                            


                     See Accompanying Notes

<PAGE 4-5>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                   CONSOLIDATED BALANCE SHEET
                                
                                
                                             In thousands
 --------------------------------------------------------------
                                        October 31,  April 30,
                                           1998         1998
 --------------------------------------------------------------
                            Assets
Current Assets:                                      
 Cash and short-term cash investments     $ 21,780    $ 27,007
 Accounts receivable                       116,170      79,114
 Inventories                                80,073      61,111
 Prepaid expenses                            9,404      18,227
                                          --------    --------
                                           227,427     185,459
                                          --------    --------
Property, Plant and Equipment              144,204     117,334
 Less accumulated depreciation              60,603      57,335
                                          --------    --------
                                            83,601      59,999
                                          --------    --------
                                                              
Intangible Assets                          240,538      99,463
 Less accumulated amortization              13,365       8,208
                                          --------    --------
                                           227,173      91,255
                                          --------    --------
Other Assets                                 1,388       2,054
                                          --------    --------
                                          $539,589    $338,767
                                          ========    ========
             Liabilities and Shareholders' Equity
                                                               

Current Liabilities:                                           
 Notes payable                            $     --    $    326
 Current maturities of long-term debt          193         193
 Accounts payable                           42,860      30,462
 Accrued compensation and benefits          18,229      17,253
 Other accrued liabilities                  40,356      30,347
 Deferred revenue                            6,872       6,619
 Advances on sales contracts                 6,367       5,498
                                          --------    --------
                                           114,877      90,698
                                          --------    --------
Noncurrent Liabilities:                                       
 Deferred income taxes                      10,208      10,202
 Long-term debt                            172,653       6,953
                                          --------    --------
                                           182,861      17,155
                                          --------    --------

Contingencies and Commitments                        
                                                     
Shareholders' Equity:                                
 Preferred stock, no par value;                                
  authorized 10,000,000 shares; no                             
  shares issued                                 --           --
 Common stock, $1.00 par value;                                
  authorized 65,000,000 shares; issued                         
  23,638,723 and 23,436,523 shares          23,639       23,437
 Paid-in capital                            39,928       37,779
 Retained earnings                         198,806      187,981
 Accumulated other comprehensive loss                          
  (foreign currency translation                                
  adjustment)                              (3,668)       (1,833)
 Unamortized value of restricted stock                         
  grants                                     (204)           --
 Treasury stock, at cost (810,000 and                          
  800,000 shares)                         (16,650)      (16,450)
                                          --------     --------
                                           241,851      230,914
                                          --------     --------
                                          $539,589     $338,767
                                          ========     ========




                     See Accompanying Notes

<PAGE 6>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
              CONSOLIDATED STATEMENT OF CASH FLOWS
                                                    In thousands
---------------------------------------------------------------------
Six Months Ended October 31,                      1998         1997
---------------------------------------------------------------------
CASH PROVIDED BY (USED FOR):                                         
                                                                     
Operating Activities                                                 
  Net earnings                                $  14,457     $ 10,067       
  Adjustments to reconcile net earnings to                          
   cash provided by operating activities:              
     Depreciation and amortization               10,729        6,604
     Deferred income taxes                         (210)          70
     Other non-cash items                           122           --
     Changes in operating accounts, net of                          
      effects of business acquisitions:
      Receivables                               (13,738)      (2,073)
      Inventories                                 8,162       (5,876)
      Prepaid expenses                           11,096        1,293
      Accounts payable and accrued expenses      (2,836)      16,300
                                               --------     --------
Provided by Operating Activities                 27,782       26,385
                                               --------     --------
Financing Activities                                                
  Purchase of common stock                          (12)     (16,400)
  Additions of long-term debt                   181,686           --
  Repayments of long-term debt                  (19,648)         (95)
  Net short-term financing                      (11,963)          --
  Debt issue costs                                 (800)          --
  Exercise of stock options                       2,037          638
  Dividends on common stock                      (3,632)      (3,670)
                                               --------     --------
Provided by (Used for) Financing Activities     147,668      (19,527)
                                               --------     --------
Investing Activities                                                
  Maturities of long-term debt securities            --        9,878
  Additions to property, plant and equipment     (7,010)      (9,715)
  Business acquisitions                        (175,952)          --
  Intangible and other assets                       362          (81)
  Other, net                                      1,923       (1,124)
                                               --------     --------
                                                                    
(Used for) Investing Activities                (180,677)      (1,042)
                                               --------     --------
                                                                    
Increase (Decrease) in Cash and Short-Term                          
  Cash Investments                               (5,227)       5,816
                                                                    
Cash and Short-Term Cash Investments,                               
  Beginning of Period                            27,007        9,503
                                               --------     --------
                                                                    
Cash and Short-Term Cash Investments,          $ 21,780     $ 15,319
  End of Period                                ========     ========
                     See Accompanying Notes

<PAGE 7>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1

The   consolidated  balance  sheet  at  October  31,  1998,   the
consolidated statements of earnings for the three- and  six-month
periods  ended  October 31, 1998 and 1997, and  the  consolidated
statement  of cash flows for the six-month periods ended  October
31,  1998  and  1997  are unaudited but, in the  opinion  of  the
Company,  include  all  adjustments, consisting  only  of  normal
recurring accruals, necessary for a fair statement of the results
for  the interim periods.  The results of operations for the six-
month   period  ended  October  31,  1998  are  not   necessarily
indicative  of  the results to be expected for  the  full  fiscal
year.

NOTE 2

The classification of inventories was as follows (in thousands):

                      October 31, 1998    April 30, 1998
                      ----------------   ---------------
Raw materials and                                       
  purchased parts              $46,957           $37,329
Work in process                 33,116            23,782
                               -------           -------
                               $80,073           $61,111
                               =======           =======

NOTE 3

In February 1997, the Financial Accounting Standards Board issued
Statement  of  Financial  Accounting Standards  (SFAS)  No.  128,
"Earnings Per Share," effective for financial statements for both
annual  and interim periods ending after December 15, 1997.  SFAS
No.  128  replaced  the  previously reported  primary  and  fully
diluted  earnings per share with basic and diluted  earnings  per
share.   Unlike  primary earnings per share, basic  earnings  per
share  excludes  any dilutive effects of options,  warrants,  and
convertible securities.  Diluted earnings per share is similar to
the  previously reported fully diluted earnings per  share.   All
earnings  per share amounts for all periods have been  presented,
and  where  necessary restated, to conform to the  SFAS  No.  128
requirements.  This restatement had an immaterial impact  on  the
prior  period  earnings  per  share amounts  under  the  previous
method.

<PAGE 8>

The  following  table  sets forth the computation  of  basic  and
diluted earnings per share:

                            Three Months              Six Months
                         Ended October 31,        Ended October 31,
                         -----------------        -----------------
                         1998         1997        1998         1997
                        -------      -------     -------      -------
Numerator:                                                             
 Net income           $ 7,735,000  $ 5,496,000 $ 14,457,000  $10,067,000
                        =========    =========   ==========   ==========
Denominators:                                                          
 Denominators for                                                      
  basic earnings per                                                   
  share--weighted-                                                     
  average shares                                                       
  outstanding          22,789,437   22,679,135  22,731,381   23,001,000
 Effect of dilutive                                                    
  securities:                                                          
  Employee stock                                                       
   options                697,116      645,571     769,047      516,597
                       ----------   ----------  ----------   ----------
  Denominator for                                                      
   diluted earnings                                                    
   per share--                                                         
   adjusted                                                            
   weighted-average                                                    
   shares                                                              
   outstanding         23,486,553   23,324,706  23,500,428   23,517,597
                       ==========   ==========  ==========   ==========
Basic earnings per                                                     
 share                $       .34  $       .24 $       .64  $       .44
                       ==========   ==========  ==========   ==========
Diluted earnings per                                                   
 share                $       .33  $       .24 $       .62  $       .43
                       ==========   ==========  ==========   ==========

NOTE 4

Beginning  in  the first quarter of FY 1999, the Company  adopted
SFAS No. 130, "Reporting Comprehensive Income," which established
standards  for reporting and displaying comprehensive income  and
its  components in an annual financial statement  with  the  same
prominence  as  other financial statements.  This statement  also
requires  that an entity report a total for comprehensive  income
in condensed financial statements of interim periods.

The  Company's  total comprehensive income  was  as  follows  (in
thousands):

<PAGE 9>

                           Three Months Ended   Six Months Ended
                               October 31,         October 31,
                             1998      1997       1998     1997
                           -------    -------   -------  -------
Net income                   $7,735    $5,496    $14,457  $10,067
Other comprehensive                                              
 income (loss):                                         
  Foreign currency                                               
   translation                                                   
     adjustments             (2,445)     (133)   (1,835)   (1,124)
                             ------    ------     ------  -------
  Total comprehensive                                            
   income                    $5,290    $5,363   $12,622   $ 8,943
                             ======    ======   =======   =======
                                                 


NOTE 5

In  June of 1998, the Financial Accounting Standards Board issued
SFAS  No. 133, "Accounting for Derivative Instruments and Hedging
Activities,"  which  must be adopted by  January  1,  2000.   The
Company is evaluating the impact of the new requirement.   At
this  time, management does not expect implementation will result
in  a  material  impact on the Company's financial  position,
results of operations, or cash flows.

Effective  May  1,  1998,  the  Company  adopted  SFAS  No.  131,
"Disclosures  about  Segments  of  an  Enterprise   and   Related
Information."   This  standard  changes  the  criteria  used   to
determine  the  segments  for which SEC registrants  must  report
information.   As  permitted by the standard,  the  Company  will
provide the required disclosures for its segments in its Form 10-
K for the year ending April 30, 1999.

Effective  May  1,  1998,  the  Company  adopted  SFAS  No.  132,
"Employers' Disclosures about Pensions and Other Post  Retirement
Benefits."   This  statement requires  additional  disclosure  on
changes in the benefit obligations and fair values of plan assets
during the year.  As permitted by the standard, the Company  will
provide  the  required disclosures for its benefit plans  in  its
Form 10-K for the year ending April 30, 1999.

NOTE 6

Included   in  other  income  for  the  six-month  period   ended
October  31, 1997 was a gain resulting from the final  settlement
of  the Company's UK patent litigation with Lectra Systemes, S.A.
of France, which added $1,563,000 to earnings before income taxes
and  approximately $1,000,000, or $.04 per diluted share, to  net
income.

<PAGE 10>

NOTE 7

On  February  27,  1998, Gerber Optical,  Inc.,  a  wholly  owned
subsidiary  of  the  Company, acquired the outstanding  stock  of
Coburn  Optical Industries, Inc. (Coburn) of Muskogee,  Oklahoma,
and  subsequently  merged with Coburn.  The company  was  renamed
Gerber  Coburn Optical, Inc. (GC).  The purchase price, including
the   costs   of  acquisition  and  the  repayment  of   Coburn's
outstanding  debt, was approximately $63,000,000.  Coburn  was  a
leading  manufacturer and international distributor  of  a  broad
range   of  ophthalmic  lens  processing  equipment  and  related
supplies  used  in  the production of eyeglass  lenses.   GC  has
continued to develop, manufacture, market, and support the Coburn
product lines.

On  May  5, 1998, the Company announced the successful completion
of  its  cash tender offer for the outstanding capital  stock  of
Spandex  PLC  (Spandex) of Bristol, UK.  Spandex was the  largest
distributor of equipment and related materials to the sign making
industry in Europe and North America. The offer valued Spandex at
approximately    $173,000,000.   In   addition,    Spandex    had
approximately $11,600,000 in outstanding debt that was assumed.

Each  acquisition was accounted for as a purchase and the results
of operations of the acquired companies have been included in the
Company's consolidated statements of earnings from the respective
dates  of  acquisition.  The acquisition costs were allocated  to
the assets and liabilities acquired based upon their fair values.
The  excess of acquisition costs over the fair values of the  net
assets acquired was included in intangible assets as goodwill and
is  being  amortized on a straight-line basis over 25 years  from
the date of acquisition.

The  following pro forma combined results of operations  for  the
three-  and  six-month periods ended October 31, 1997  have  been
prepared  as  if the Coburn and Spandex acquisitions occurred  at
May  1, 1997 and give effect to estimated purchase accounting and
other adjustments resulting from the acquisitions.  The pro forma
information  is presented on the assumption that the  acquisition
costs  would  have been the same at May 1, 1997.  The  pro  forma
financial  information  is  not  necessarily  indicative  of  the
results  of  operations  that would have been  achieved  had  the
acquisitions of Coburn and Spandex actually been effective as  of
May 1, 1997 or of future results of the combined companies.

<PAGE 11>

                           (Unaudited)           (Unaudited)
                         ---------------        -------------
                       Three Months Ended     Six Months Ended
                           October 31,           October 31,
                       ------------------    -------------------
In thousands                                                   
(except per share                                              
 amounts)                     1997                  1997
--------------------   ------------------   -------------------
Sales                            $164,042              $319,021
Net earnings                        6,066                10,886
Net earnings per                                               
 common share-basic                   .27                   .47
Net earnings per                                               
 common share-diluted                 .26                   .46
                                                                 

<PAGE 12>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES

With  respect to the unaudited consolidated financial  statements
of  Gerber Scientific, Inc. and subsidiaries at October 31,  1998
and  for the three- and six-month periods ended October 31,  1998
and  1997,  KPMG  Peat Marwick LLP has made a  review  (based  on
procedures adopted by the American Institute of Certified  Public
Accountants)  and  not an audit, as set forth in  their  separate
report dated November 18, 1998 appearing on page 13.  That report
does not express an opinion on the interim unaudited consolidated
financial information.  KPMG Peat Marwick LLP has not carried out
any  significant  or  additional audit tests beyond  those  which
would  have been necessary if their report had not been included.
Accordingly,  such  report  is not a "report"  or  "part  of  the
Registration Statement" within the meaning of Sections 7  and  11
of  the  Securities Act of 1933 and the liability  provisions  of
Section 11 of such Act do not apply.


<PAGE 13>

                 INDEPENDENT ACCOUNTANTS' REPORT


To the Board of Directors and Shareholders of
Gerber Scientific, Inc.


We  have made a review of the consolidated statements of earnings
of  Gerber  Scientific, Inc. and subsidiaries for the three-  and
six-month   periods  ended  October  31,  1998  and   1997,   the
consolidated  statement of cash flows for the  six-month  periods
ended  October  31,  1998 and 1997, and the consolidated  balance
sheet  as  of  October  31,  1998 in  accordance  with  standards
established  by  the  American  Institute  of  Certified   Public
Accountants.   We  have previously audited,  in  accordance  with
generally   accepted  auditing  standards,  and   expressed   our
unqualified  opinion  dated  May 21,  1998  on  the  consolidated
financial  statements  for the year ended  April  30,  1998  (not
presented  herein).  The aforementioned financial statements  are
the responsibility of the Company's management.

A review of interim financial information consists principally of
applying  analytical  review procedures  to  financial  data  and
making  inquiries  of  persons  responsible  for  financial   and
accounting  matters.  It is substantially less in scope  than  an
examination  in  accordance  with  generally  accepted   auditing
standards, the objective of which is the expression of an opinion
regarding   the   financial  statements   taken   as   a   whole.
Accordingly, we do not express such an opinion.

Based   on   our  review,  we  are  not  aware  of  any  material
modifications   that   should  be  made   to   the   accompanying
consolidated statements of earnings for the three- and  six-month
periods  ended  October  31,  1998  and  1997,  the  consolidated
statement  of cash flows for the six-month periods ended  October
31,  1998  and  1997,  or the consolidated balance  sheet  as  of
October  31,  1998  for them to be in conformity  with  generally
accepted   accounting  principles.  Also,  in  our  opinion   the
information in the accompanying consolidated balance sheet as  of
April 30, 1998 is fairly presented, in all material respects,  in
relation to the consolidated balance sheet from which it has been
derived.


/s/ KPMG PEAT MARWICK LLP


Hartford, Connecticut
November 18, 1998


<PAGE 14>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
             MANAGEMENT'S DISCUSSION AND ANALYSIS OF
          FINANCIAL CONDITION AND RESULTS OF OPERATIONS


OVERVIEW

In  May  1998,  the  Company acquired the  outstanding  stock  of
Spandex PLC (Spandex).  Accordingly, Spandex was included in  the
Company's consolidated balance sheet at October 31, 1998, in  the
Company's  results from operations for the three-  and  six-month
periods  ended October 31, 1998, and in the Company's cash  flows
for the six-month period ended October 31, 1998.

In  February 1998, the Company acquired the outstanding stock  of
Coburn Optical Industries, Inc. (Coburn).  Coburn was included in
the  Company's consolidated balance sheet at April 30,  1998,  in
the  Company's  results from operations for the three-  and  six-
month  periods ended October 31, 1998, and in the Company's  cash
flows for the six-month period ended October 31, 1998.

In  March  1998, the Company sold its Gerber Systems unit,  which
comprised  the  Company's imaging and inspection systems  product
class.   As  a  result, the Company's April 30, 1998 consolidated
balance  sheet and the FY 1999 consolidated financial  statements
do not include any Gerber Systems activity.

FINANCIAL CONDITION

The  Company's ratio of current assets to current liabilities was
2.0  to  1  at October 31, 1998 and April 30, 1998.  Net  working
capital  at  October 31, 1998 was $112.5 million, an increase  of
$17.8  million from the beginning of the current fiscal year  and
largely  attributable to the Spandex acquisition.  The  Company's
cash  and  investments totaled $21.8 million at October 31,  1998
compared with $27 million at the end of the prior fiscal year.

Operating activities provided $27.8 million in cash for the  six-
month  period ended October 31, 1998 compared with $26.4  million
provided  by operating activities for the same period last  year.
Cash  in  this year's first six months was generated by  earnings
and the non-cash charges for depreciation and amortization, lower
inventory balances, and a tax refund resulting from the  sale  of
the  Company's imaging and inspection systems product class. Cash
generated from operations was somewhat offset by higher  accounts
receivable balances caused by the higher volume of business.

The  principal non-operating use of cash in the six months  ended
October  31,  1998  was for the purchase of  Spandex  for  $187.6
million,  which included the repayment of its debt. The financing
for  the  acquisition was provided primarily by a five-year  $235
million  revolving  multi-currency credit  facility  the  Company
entered  into  with  a group of major U.S., European,  and  Asian
commercial  banks. Other non-operating uses of cash  in  the  six

<PAGE 15>

months  ended October 31, 1998 were repayments of long-term  debt
of  $19.6 million, additions to property, plant, and equipment of
$7.0  million,  and  payment of dividends of $3.6  million.   The
Company  anticipates that capital expenditures  for  the  current
fiscal  year will be in the range of $20-$22 million and  expects
to fund these with cash on hand and cash from operations.

The  Company's total debt at October 31, 1998 was $172.8 million,
which  was  up substantially from the April 30, 1998  balance  of
$7.5  million and caused by the acquisition of Spandex. Net  debt
(total  debt  less  cash and investments) was $151.1  million  at
October  31, 1998 versus a net cash position of $19.5 million  at
April 30, 1998.  The ratio of net debt to total capital was  38.4
percent at October 31, 1998.

RESULTS OF OPERATIONS

Combined  sales and service revenue for the three- and  six-month
periods  ended  October 31, 1998 increased  $44.2  million  (41.5
percent) and $98.9 million (48.2 percent), respectively, from the
same  periods  last year.  The increase reflected higher  product
sales,  predominantly from the acquisitions of Spandex (increases
of  $39.0 million and $81.8 million in sales for three- and  six-
month  periods  ended  October  31,  1998,  net  of  intercompany
eliminations,  respectively)  and  Coburn  (increases  of   $16.4
million  and $33.6 million in sales for the three- and  six-month
periods  ended October 31, 1998, respectively). The sale  of  the
Company's  imaging and inspection system product  class  in  last
year's fourth quarter was an offsetting factor ($13.3 million and
$22.8  million in sales in the three- and six-month periods ended
October 31, 1997).  In addition, there was internal sales  growth
in  the Company's core operations, which came predominantly  from
higher sales of the Company's optical lens manufacturing systems.
Service  revenue  also increased $2.7 million  (27.3  percent)and
$4.1 million (20.2 percent) from the prior year's three- and six-
month   periods  ended  October  31,  1997,  respectively,  after
adjusting  for  the elimination of the service revenue  from  the
imaging  and  inspection systems products.  These increases  were
caused  predominantly by the acquisitions of Spandex  and  Coburn
and   also  from  growth  in  the  Company's  continuing  service
operations.

The  consolidated  gross profit margin in this year's  first  six
months  was  41.1 percent, which was lower than  the  prior  year
margin  of  43.9 percent.  Gross profit margins on product  sales
were  lower, while service margins were higher.  The decrease  in
product  gross  profit  margins was caused predominantly  by  the
inclusion of Spandex in the Company's financial statements in  FY
1999.   As  a  distributor,  Spandex  has  gross  profit  margins
substantially  lower  than  the  Company's.  However,   Spandex's
historical  operating margins are incrementally higher  than  the
Company's recent operating margins, owing in part to the  absence
of  R&D  spending.  Also reducing the product gross profit margin
in  this  year's  second quarter and first  six  months  was  the

<PAGE 16>

inclusion of Coburn. A larger percentage of Coburn's product  mix
comes  from  sales  of aftermarket products (e.g.,  consumables),
which have gross profit margins lower than equipment sales.

Service  gross  profit margins were higher in this year's  second
quarter  and first six months than in the prior year's comparable
periods.   The increases were caused primarily by the elimination
of   the  low  service  margins  of  the  Company's  imaging  and
inspection  systems product class, which were  included  in  last
year's results. Also affecting the increases were higher sales of
service  contracts  for  production data management  systems  and
single-ply  cutters,  both  in the  apparel  and  flexible  goods
industries.

Selling,  general,  and administrative expenses  in  this  year's
second  quarter  and first six months rose by  $7.8  million  and
$18.6  million  from last year but declined as  a  percentage  of
revenue  to  26.3 percent and 26.7 percent this  year  from  29.9
percent  and  30.5  percent last year.  The  Spandex  and  Coburn
acquisitions were the principal reasons for the dollar  increase,
while the sale of the imaging and inspection system product class
was  an offsetting factor. The amortization of Spandex and Coburn
acquisition  goodwill  ($1.9 million and  $3.8  million  in  this
year's  second  quarter and first six months,  respectively)  was
also a factor contributing to the overall dollar increase.

The Company continued to commit significant resources to research
and  the development of new products.  However, the ratio of  R&D
to revenue declined significantly this year.  R&D expense of $7.6
million  in this year's second quarter and $15.3 million  in  the
first  six  months was roughly the same as the prior year,  while
the  ratio  of  R&D  to revenue declined to  5.1  percent  and  5
percent, respectively, in the second quarter and first six months
this  year from 7.3 percent and 7.5 percent last year.  The lower
current year ratio was caused by the significantly higher revenue
base  from  the  Spandex  acquisition  without  commensurate  R&D
expense  as Spandex is predominantly a distribution company.   In
addition  to the incremental R&D expenses of Coburn,  R&D  dollar
increases for the three- and six-month periods ended October  31,
1998  were  also  related to the development of new  sign  making
plotters  and  output  devices ($0.2 million  and  $0.8  million,
respectively),  ophthalmic  lens  manufacturing   systems   ($0.7
million  and  $1.4 million, respectively), and automated  cutting
systems  ($0.5  million  and $0.7 million,  respectively).  These
increases were offset by the elimination of the Company's imaging
and  inspection system product class. Management anticipates that
this lower ratio of R&D expense to revenue will continue for  the
balance of the current year.

Compared  to  the prior year, other income in this year's  second
quarter was slightly higher, while lower for the six months ended
October 31, 1998. The year-to-year decrease related predominantly
to  a  prior  year gain of approximately $1.6 million  ($.04  per

<PAGE 17>

diluted  share)  from the final settlement of outstanding  patent
litigation.

Interest expense increased $3.3 million and $6.3 million  in  the
three- and six-month periods ended October 31, 1998 compared with
the   prior   year  periods.  These  increases  were  caused   by
significantly higher debt balances for cash borrowed  to  finance
the  acquisition  of Spandex.  The majority of  these  borrowings
were  against  a  five-year $235 million revolving multi-currency
credit  facility.   The  interest rate  on  these  borrowings  is
variable  and  is  based  on the London  Interbank  Offered  Rate
(LIBOR)  for the relevant currency and term, plus a margin  based
on  the relationship of the Company's consolidated total debt  to
EBITDA  (earnings  before  interest,  taxes,  depreciation,   and
amortization).

The  provision  rate for income taxes was 37.3  percent  for  the
second  quarter and 37.6 percent for the six months ended October
31,  1998  compared  with 32.1 percent and 32.3  percent  in  the
comparable prior year periods.  The higher tax rate this year was
primarily the result of the goodwill amortization related to  the
acquisitions  of Spandex and Coburn, which is not deductible  for
Federal and state income tax purposes.  The year-to-year increase
in  the  provision rate also reflects the higher marginal  income
tax  rates  associated with higher levels of pre-tax earnings  in
the current year and the liquidation of the Company's investments
in tax-exempt municipal securities.

As  a  result of the above, net earnings increased in this year's
second quarter to $7.7 million or $.33 diluted earnings per share
from  $5.5  million or $.24 diluted earnings per  share  in  last
year's  second quarter.  For the first six months,  net  earnings
this  year  increased to $14.5 million or $.62 per diluted  share
compared with $10.1 million or $.43 per diluted share last  year.
Earnings per share in last year's first quarter included $.04 per
diluted share from the patent litigation settlement.

YEAR 2000

The  Company recognizes the business risks posed by the Year 2000
computer date issue.  The Company continues to make this issue  a
top  business  priority and is actively working  to  control  the
associated  risks.  Each  Gerber  Scientific  business  unit  has
project  teams  to address the impact of the Year 2000  on  their
products and facilities, internal systems, and key suppliers  and
customers.   These project teams are responsible  for  Year  2000
awareness,  assessment,  remediation,  testing,  and  contingency
planning.   These  project teams report to business  unit  senior
management.   In addition, the Company has a Year 2000  Corporate
Oversight Committee that reports to Executive Management  and  to
the Board of Directors.

The  Company has completed its Year 2000 awareness phase and  has
substantially completed the assessment phase.  The Company is  in

<PAGE 18>

the  process of carrying out the remediation and testing  phases,
which are expected to be substantially completed by May 1, 1999.

Testing  of manufactured products, including internally developed
software, has been completed for most of the business units.  The
results  of  this  testing  are being communicated  to  customers
through the Company's web sites.

Some  of  the Company's internal systems are third party packages
that  were implemented without modification.  In these instances,
only  software upgrades were required for Year 2000  remediation,
which are now being tested.  Additionally, the  Company  is
implementing an enterprise resource planning system  across  each
of  its  businesses.   Although this system implementation  is  a
direct  result of a key management initiative to install improved
business  processes, it also enables the remediation  of  certain
legacy  systems that are not Year 2000 compliant in one business
unit.

The  Company  is also taking steps to understand  the  Year  2000
risks  of  its significant suppliers and customers.  As  part  of
that  process,  the  Company is sending questionnaires  to  those
third  parties  and  analyzing the responses.  Further  analysis,
including  site  visits,  will be conducted  as  necessary.   The
Company  intends  to  work directly with its  key  suppliers  and
customers  to avoid any business interruptions.  As issues  arise
in  this  analysis, contingency plans will be developed.  Despite
these efforts, the Company can provide no assurance that supplier
and customer Year 2000 plans will be successfully completed in  a
timely manner.

Year 2000 expenditures, which are expected to be immaterial,  are
planned  to  be  incurred by April 30, 1999 and  funded  through
operating  cash  flows.   The schedule  for  completion  and  the
estimated  associated costs are based on management's  estimates,
which  include  assumptions of future events.  There  can  be  no
assurance  that the Company and its suppliers and customers  will
be  fully  Year 2000 compliant by January 1, 2000.  The  Company,
therefore, could be adversely impacted by such things as loss  of
revenue,  production delays, lack of third party  readiness,  and
other  business interruptions. Accordingly, the Company has begun
developing  contingency plans to address potential  issues,  which
include  identification  of alternate  suppliers.   The  ultimate
effects on the Company or its suppliers or customers of not being
fully  Year 2000 compliant is not reasonably estimable.  However,
the  Company believes its Year 2000 remediation efforts, together
with  the  diverse  nature  of its businesses,  help  reduce  the
potential impact of noncompliance to levels that will not have  a
material  adverse  impact on its financial position,  results  of
operations, or cash flows.

<PAGE 19>

EURO CONVERSION

On  January  1,  1999, certain member countries of  the  European
Union  are scheduled to establish fixed conversion rates  between
their   existing  currencies  and  the  European  Union's  common
currency  (Euro).  The transition period for the introduction  of
the  Euro  will be between January 1, 1999 and January 2,  2002.
The  Company  has  begun to identify and  ensure  that  all  Euro
conversion  compliance issues are addressed.  At this  time,  the
Company  cannot predict the impact of the Euro conversion because
of  numerous associated uncertainties, such as the effect on  the
Company of noncompliance by third parties.

FORWARD-LOOKING STATEMENTS

This report includes forward-looking statements that describe the
Company's  business  prospects.   Readers  should  keep  in  mind
factors  that  could have an adverse impact on  those  prospects.
These  include political, economic, or other conditions, such  as
recessionary  or  expansive  trends,  inflation  rates,  currency
exchange  rates,  taxes,  regulations  and  laws  affecting   the
business, as well as product competition, pricing, the degree  of
acceptance of new products in the marketplace, and the difficulty
of forecasting sales at various times in various markets.



<PAGE 20>

                   PART II - OTHER INFORMATION

Item 4.  Submission of Matters to a Vote of Security Holders

On  September  25, 1998, the Company held its annual  meeting  of
shareholders.  The holders of 87 percent of the shares of  common
stock  entitled  to vote at this meeting were present  either  in
person  or  by proxy.  The following were the voting results  for
the meeting:

   -    the shareholders approved the Annual Incentive Bonus Plan
      for Fiscal Years 1999 through 2001 with 18,692,723 votes in
      favor, 998,833 votes against, and 72,539 abstentions. Votes not
      cast totaled 203.

   -    the shareholders approved the Amended/Restated 1992 Employee
      Stock  Plan with 13,494,665 votes in favor, 4,387,540 votes
      against,  and  81,068 abstentions.  Votes not cast  totaled
      1,801,025.

   -     the shareholders approved the Amended/Restated 1992 Non-
      Employee Director Stock Option Plan with 16,434,228 votes in
      favor, 3,237,885 votes against, and 92,184 abstentions. One vote
      was not cast.

   -    the shareholders elected Directors to hold office until the
      annual meeting to be held in the year 2001 with the following
      votes:
                                   For            Withheld

      Donald P. Aiken          18,371,548       1,392,750
      George M. Gentile        18,210,348       1,553,950
      David J. Gerber          18,210,448       1,553,850
      
      The  terms  of  office of the other Directors,  Michael  J.
      Cheshire,  Edward  E.  Hood,  David  J.  Logan,  Carole  F.
      St.   Mark,  A.  Robert  Towbin,  and  W.  Jerome   Vereen,
      continued after the meeting.
      
Item 5.  Other Information

On June 1, 1998, the Company issued a press release reporting the
retirement  of  George M. Gentile, Chairman and  Chief  Executive
Officer  of Gerber Scientific, Inc.  Effective June 1, 1998,  Mr.
Gentile  stepped  down  from  his  position  as  Chief  Executive
Officer.  The Company's Board of Directors appointed  Michael  J.
Cheshire,  who was President and Chief Operating Officer  of  the
Company,  as  President  and  Chief  Executive  Officer.  At  the
Company's  Annual Meeting of Shareholders on September 25,  1998,
Mr.  Gentile  retired as Chairman of the Board of Directors.  Mr.
Cheshire also succeeded Mr. Gentile as Chairman on September  25,
1998.

<PAGE 21>

Item 6.  Exhibits and Reports on Form 8-K

(a)  Exhibits

     (15) Letter    regarding    unaudited   interim    financial
          information.

     (27) Financial data schedule.

(b)  Reports on Form 8-K

     No  Form  8-K  was filed during the quarter for  which  this
     report is filed.

<PAGE 22>

                            SIGNATURE


Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the Registrant has duly caused this report to be signed  on
its behalf by the undersigned, thereunto duly authorized.




                               GERBER SCIENTIFIC, INC.
                              ------------------------
                                    (Registrant)




Date:   December 14, 1998    By:  / s / Gary K. Bennett
        ------------------       --------------------------------
                                 Gary K. Bennett
                                 Senior Vice President, Finance
                                 and Principal Financial Officer

<PAGE 23>

                          EXHIBIT INDEX




Exhibit Index                                                 
    Number                    Exhibit                       Page
-------------                 -------                       ----
                                                      
      15        Letter  Regarding Unaudited  Interim          
                Financial Information.*
                                                      
      27        Financial Data Schedule.*             




*Filed herewith.